15 /100
LOW RISK
Score updated May 29, 2026

CGEM — Cullinan Therapeutics, Inc. Dilution Risk Tracker

Track CGEM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CGEM — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CGEM.
🔔 Track CGEM — Get forecast alerts →

💹 Market Data

Market Cap$944.00M
Shares Outstanding61.46M
Float44.27M
Cash$351.88M
Debt$2.38M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 7.8% shares (2025Q4 vs prior)
154 institutional holders · 66.80M shares
#1 Lynx1 Capital Management LP 8.96M shares
#2 MPM BIOIMPACT LLC 7.65M shares
#3 BVF INC/IL 5.75M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest8.80M
Days to Cover15.3
% of Float19.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Sep 30, 2022
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 25, 2026
4 INSIDER TRANSACTION Feb 25, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track CGEM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CGEM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for CGEM
📊 CGEM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CGEM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.